| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
76 Outperform | €2.55B | 16.88 | 6.98% | 2.08% | -0.23% | -37.70% | |
76 Outperform | €1.32B | 16.64 | 12.87% | 0.84% | 7.00% | 20.56% | |
75 Outperform | €707.60M | 20.44 | 12.87% | 2.54% | 1.02% | 6.31% | |
74 Outperform | €20.19B | 12.98 | 14.30% | 2.35% | -0.76% | -6.99% | |
65 Neutral | €2.74B | 9.80 | 14.39% | 3.03% | -4.12% | 43.37% | |
52 Neutral | €1.01B | 0.60 | ― | ― | -14.60% | ― |